Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel S. Woloshen currently holds 22,033 shares of GTC BIOTHERAPEUTICS INC (GTCB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel S. Woloshen has been a net seller of GTCB stock. They have purchased $1.1K and sold $17.9K worth of shares.
Daniel S. Woloshen's most recent insider trade was on Nov 2, 2009, when they sold 11,717 shares at $1.21 per share.
Daniel S. Woloshen serves as Executive at GTC BIOTHERAPEUTICS INC (GTCB). They have executed 12 insider transactions totaling $19.0K over their tenure at the company.
Daniel S. Woloshen holds the position of Executive at GTC BIOTHERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Daniel S. Woloshen has shown a selling trading pattern, with $1.1K in total purchases and $17.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniel S. Woloshen was on Nov 2, 2009, when they purchased $15.8K worth of GTCB shares. This transaction involved 13,086 shares at $1.21 per share.
Daniel S. Woloshen currently owns 22,033 shares of GTC BIOTHERAPEUTICS INC (GTCB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel S. Woloshen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel S. Woloshen has 12 Form 4 filings on record as an insider at GTC BIOTHERAPEUTICS INC.
Set alerts for Daniel S. Woloshen and 40,000+ other insiders.